New Horizon Health IPO Initiation: Screening for Cancer
New Horizon will have a listing hearing for a $300 million HK IPO this week. We believe that New Horizon has the right ingredients to capitalise on...
597 Views
Eddingpharm: First Impressions
Eddingpharm plans to list on the HKEX. This Insight analyzes the company's products and pipeline. The main question is whether enthusiasm for the...
493 Views
Cansino Biologics Placement - Past Deal Didn't Do Well, Losing the Vaccine Race
Lilly Asia is looking to raise around US$180m via selling a 6% stake in CanSino Biologics Inc (6185 HK)'s H-shares. Lilly Asia last sold its stake...
564 Views
China Healthcare Weekly (Oct.9)
This insight summarized the important industry viewpoints, news of listed healthcare companies and capital market review for the last week of China...
399 Views